Fidelity Investments
CGON icon

Fidelity Investments’s CG Oncology CGON Stock Holding History

Fidelity Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296M Buy
4,161,493
+396,649
+11% +$25.9M 0.01% 765
2026
Q1 		$255M Sell
3,764,844
-533,329
-12% -$30.2M 0.01% 762
2025
Q4 		$178M Buy
4,298,173
+432,371
+11% +$17.9M 0.01% 914
2025
Q3 		$156M Buy
3,865,802
+9,541
+0.2% +$277K 0.01% 959
2025
Q2 		$100M Buy
3,856,261
+1,311,163
+52% +$31.6M 0.01% 1115
2025
Q1 		$62.3M Buy
2,545,098
+111,505
+5% +$3.14M ﹤0.01% 1279
2024
Q4 		$69.8M Buy
2,433,593
+2,287,987
+1,571% +$78.3M ﹤0.01% 1262
2024
Q3 		$5.49M Buy
145,606
+145,432
+83,582% +$5.1M ﹤0.01% 2100
2024
Q2 		$5.49K Buy
174
+17
+11% +$589 ﹤0.01% 4518
2024
Q1 		$6.89K Buy
+157
New +$6.41K ﹤0.01% 4405

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's CGON Position: Q2 2026 in Review

Fidelity Investments increased its CG Oncology (CGON) stake by 11% in Q2 2026, buying an estimated $25.9M and bringing the position to 4,161,493 shares worth $296M. The position accounts for 0.01% of the portfolio, ranked #765.

Fidelity Investments first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Fidelity Investments held 4,161,493 shares of CG Oncology worth $296M as of Q2 2026.
  • Fidelity Investments bought 396,649 CG Oncology shares in Q2 2026, an estimated $25.9M.
  • CG Oncology made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #765 holding.
  • Fidelity Investments first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.